Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials

Anne M Durkan, Elisabeth M. Hodson, Narelle S. Willis, Jonathan C. Craig

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Background

Many children with steroid-sensitive nephrotic syndrome (SSNS) relapse frequently and receive immunosuppressive agents. In this systematic review of randomized controlled trials (RCTs), the benefits and harms of these immunosuppressive agents are evaluated.
Methods

RCTs with outcome data at six months or more that evaluated noncorticosteroid agents in relapsing SSNS were included. A summary relative risk for relapse at 6 to 12 months was calculated using a random effects model.
Results

Seventeen trials involving 631 children were identified. Cyclophosphamide [3 trials; relative risk (RR) 0.44, 95% confidence interval (CI), 0.26 to 0.73] and chlorambucil (2 trials; RR 0.13, 95% CI, 0.03 to 0.57) significantly reduced the relapse risk at 6 to 12 months compared with prednisone alone. In the single chlorambucil versus cyclophosphamide trial, there was no observed difference in relapse risk at two years (RR 1.31, 95% CI, 0.80 to 2.13). Cyclosporine was as effective as cyclophosphamide (1 trial; RR 1.07, 95% CI, 0.48 to 2.35) and chlorambucil (1 trial; RR 0.82, 95% CI, 0.44 to 1.53), but the effect was not sustained when cyclosporine was ceased. During treatment, levamisole (3 trials; RR 0.60, 95% CI, 0.45 to 0.79) was more effective than steroids alone, but the effect was not sustained.
Conclusions

Cyclophosphamide, chorambucil, cyclosporine, and levamisole reduce the risk of relapse in children with relapsing SSNS compared with prednisone alone. Clinically important differences in efficacy among these agents are possible, and further comparative trials are still needed. Meanwhile, the choice between these agents depends on physician and patient preferences related to therapy duration and complication type and frequency.
Original languageEnglish
Pages (from-to)1919-1927
Number of pages9
JournalKidney International
Volume59
Issue number5
DOIs
Publication statusPublished - 2001
Externally publishedYes

Keywords

  • children
  • nephrotic syndrome
  • immunosuppressive therapy

Fingerprint Dive into the research topics of 'Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

  • Cite this